PPH Legal Blog

Bayer Schering Pharma has reported positive findings during the first round of clinical trials for its oral pulmonary hypertension treatment, Riociguat. The development of this drug is the first in its class of vasodilating agents.
The trials, being successful so far, will now move onto a Phase III study in late 2008 to determine the full […]

[Read more →]

A Texas police chief who was trying to stay trim back in the 1990s has recently learned the true effects of the Metabolife that he took to stay thin. Unfortunately, the Metabolife contained primary pulmonary hypertension causing ephedra.
According to Leo Longoria, the police chief, he began to experience a rapid heart rate and high blood […]

[Read more →]

Over a dozen new Avandia lawsuits were filed in late August, after many more people have suffered the dangerous effects of Avandia, a drug meant to treat diabetes. The new lawsuits have one common claim - patients were never warned about the dangerous effects of the drug.
Many people have developed a heart condition known as […]

[Read more →]

Lany Standford, a type 2 diabetic, died after suffering a heart attack in May, 2007. He had been prescribed Avandia to regulate his insulin levels; however, the drug turned out to be more dangerous than the condition it was meant to treat.
Stanford’s family has filed a wrongful death lawsuit against the manufacturer, GlaxoSmithKline. According to […]

[Read more →]

The United States Food and Drug Administration has been investigating the drug Avandia for some time now. In early 2008, the FDA issued a warning letter to the drug’s manufacturer, GlaxoSmithKline, for postmarketing safety reporting failures.
The large manufacturer claims that any information that was withheld was done so by mistake. GlaxoSmithKline states that the missing […]

[Read more →]